Global Bioprocess Automation Market Size To Exceed USD 17.2 Billion by 2035| CAGR of 10.22%
Category: HealthcareAccording to a research report published by Spherical Insights & Consulting, The Global Bioprocess Automation Market Size is Expected To Grow from USD 5.9 Billion in 2024 to USD 17.2 Billion by 2035, at a CAGR of 10.22% during the Forecast Period 2025-2035.
Get more details on this report -
Browse key industry insights spread across 240 pages with 120 Market data tables and figures & charts from the report on the "Global Bioprocess Automation Market Size, Share, and COVID-19 Impact Analysis, By Type of Controllers (Upstream controllers, Downstream controller, and Bioprocess control software), Scale of Operation (Preclinical, Clinical operations, and Commercial operations), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 – 2035." Get Detailed Report Description Here: https://www.sphericalinsights.com/reports/bioprocess-automation-market
The bioprocess automation market refers to the industry that focuses on the automated systems and services used for monitoring, controlling, and optimizing bioprocessing workflow, particularly in biopharmaceutical manufacturing. Bioprocessing automation uses advanced technologies like robotics, sensors, and data analytics for managing bioproduction intricacies, addressing the need for biologics, streamlining production, and maintaining rigorous quality standards. An increasing need for efficient and consistent production of biologics and vaccines is driving the growth of bioprocess automation. Further, integration of AI, machine learning, and digital twins in bioprocess 4.0, which are promoting next-generation biomanufacturing, is offering market growth opportunities. An increasing demand for biologics and a focus on personalized medicine are primarily driving the market demand for bioprocess automation. Further, concern regarding the increasing prevalence of cancer & other chronic diseases, surging the need for cell-based therapies. On the contrary, the heightened cost of bioprocessing equipment and strict regulatory requirements are hampering the market.
The upstream controllers segment dominated the market with the largest revenue share in 2024 and is projected to grow at a substantial CAGR during the forecast period.
Based on the type of controllers, the bioprocess automation market is divided into upstream controllers, downstream controller, and bioprocess control software. Among these, the upstream controllers segment dominated the market with the largest revenue share in 2024 and is projected to grow at a substantial CAGR during the forecast period. Upstream controllers in bioprocessing are used during the stage from cell line development and cultivation to culture expansion of the cells through harvest. An increasing need for biologics, biosimilars, and advanced cell & gene therapies is contributing to driving the market demand.
The preclinical segment accounted for a significant share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period.
Based on the scale of operation, the bioprocess automation market is divided into preclinical, clinical operations, and commercial operations. Among these, the preclinical segment accounted for a significant share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period. Bioprocess automation aids in the production of vaccines, monoclonal antibodies, and gene therapy vectors. The increasing demand for rapid, cost-effective testing of biologics, with a focus on early-stage drug development, aids in propelling the market demand in the preclinical segment.
North America is expected to hold the majority share of the global bioprocess automation market during the forecast period.
Get more details on this report -
North America is expected to hold the majority share of the global bioprocess automation market during the forecast period. Integration of cloud-based platforms and AI for enhancing data-driven decision-making and predictive analytics contributes to propelling market growth. Further, the region’s increasing presence of leading biopharmaceutical companies and advanced R&D infrastructure is responsible for driving the market.
Asia Pacific is anticipated to grow at the fastest pace in the global bioprocess automation market during the forecast period. An increasing production of biopharmaceuticals such as recombinant proteins and vaccines is contributing to supporting the market demand. An increased investment in biotechnology research and expanding biopharmaceutical manufacturing capabilities are driving the bioprocess automation market in the region.
Major vendors in the global bioprocess automation market are Cytiva Lifesciences, Thermo Fisher Scientific, Sepragen, Repligen, Applikon Biotechnology, Sartorius, Solaris Biotech, Sysbiotech, Merck KGaA, Corning, Danaher, Thermo Fisher, Emerson, Eppendorf, 3Bar Biologics, Lonza Group AG, and Others.
Key Target Audience
- Market Players
- Investors
- End-users
- Government Authorities
- Consulting and Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
Key Market Development
- In March 2025, Prendio-BioProcure, announced the launch of its most advanced set of capabilities to date, enabling cost savings, further workflow automation, and supplier intelligence to R&D-driven organizations.
- In February 2025, the Cultivated B announced the launch of multi-channel biosensors that would set benchmarks in monitoring growth and metabolism of cell culture and fermentation processes.
- In January 2025, Sartorius and McMaster University have opened a 1,600 square foot bioprocess research facility in Hamilton, Ontario, about 38 miles south of Toronto. The automation laboratory, located at the university’s Faculty of Engineering, is a training and development hub for bioprocess modelling, simulation, and advanced control.
Market Segment
This study forecasts revenue at global, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the bioprocess automation market based on the below-mentioned segments:
Global Bioprocess Automation Market, By Type of Controllers
- Upstream controllers
- Downstream controller
- Bioprocess control software
Global Bioprocess Automation Market, By Scale of Operation
- Preclinical
- Clinical operations
- Commercial operations
Global Bioprocess Automation Market, By Regional Analysis
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- UAE
- Saudi Arabia
- Qatar
- South Africa
- Rest of the Middle East & Africa
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Need help to buy this report?